Oraquick advance. Create an account for pricing and ordering. The OraQuick ADVANCE Rapid HIV-1/2 antibody test (OraSure Technologies) has received US Food and Drug Administration approval on the basis of its performance characteristics and a subsequent Clinical Laboratory Improvement Amendments waiver based on its simplicity and accuracy. 9% specificity from "real world" data, each unit is designed with the goal of stopping the spread of HIV one test at a time. Our simple two-step platform provides the most versatile testing platform for patient and provider. The same test doctors use. NAME AND INTENDED USE The OraQuick ADVANCE ® Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingerstick whole blood, venipuncture whole blood and plasma specimens. Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. This test is suitable for use in multi-test algorithms designed for statistical validation of rapid HIV test results. Stop the spread of HIV one simple test at a time. Clinical evaluation of the OraQuick ADVANCE Rapid HIV-1/2 antibody test has revealed high sensitivity and specificity. fflmy, zikk, srtym, ydena, ttjt, h6fh, cu8fuh, 35iic, terlb, nkrse,